Summary
Reconstituted peptides must be refrigerated. Lyophilised (powder) peptides can tolerate short periods at room temperature but last significantly longer when kept cool. This guide explains what each format requires and why.
The Simple Answer
Reconstituted peptides: always refrigerate. Once a lyophilised peptide has been dissolved in bacteriostatic water, it must be kept at 2–8°C. Leaving it at room temperature — especially in warm climates — causes significant and often irreversible degradation.
Lyophilised (powder) peptides: refrigerate strongly recommended. They can survive brief room-temperature exposure, but refrigeration maximises shelf life and is standard practice.
Why Temperature Matters
Peptides are chains of amino acids. The bonds holding them together and the biological activity they carry are sensitive to heat. At higher temperatures:
- Hydrolysis accelerates: Water molecules break peptide bonds — faster at higher temperatures
- Oxidation increases: Vulnerable amino acid side chains degrade when warm
- Aggregation occurs: Peptide molecules cluster into inactive particles
- Bacterial growth rises: In reconstituted solutions, warm temperatures allow bacteria to multiply, further degrading the compound
The relationship between temperature and degradation rate is not linear — small temperature increases produce disproportionately large increases in degradation speed.
Lyophilised vs Reconstituted: Different Requirements
Lyophilised (Freeze-Dried) Powder
Lyophilisation removes water — the medium in which most degradation reactions occur. This makes freeze-dried peptides dramatically more stable than their reconstituted counterparts.
- Room temperature (20–25°C): Acceptable for short periods (transit, brief storage). Avoid extended exposure.
- Refrigerator (2–8°C): Recommended for routine storage. Shelf life: 12–24 months for most compounds.
- Freezer (−20°C): Appropriate for long-term archiving beyond 12 months.
Reconstituted in Bacteriostatic Water
Once reconstituted, the peptide is in aqueous solution and degradation processes resume.
- Room temperature: Not recommended for more than a few hours. Stability drops rapidly above 8°C.
- Refrigerator (2–8°C): Required. Shelf life: 28–60 days depending on compound.
- Freezer (−20°C): Suitable for single-use aliquots stored long-term — freeze once, thaw once, use completely.
Bali-Specific Considerations
In Bali's climate (typically 28–33°C ambient temperature), the stakes are higher than in cooler environments:
- A reconstituted peptide left on a desk or nightstand for even a few hours may have lost meaningful activity
- Power outages can leave refrigerated vials at ambient temperature for extended periods
- Delivery services using standard motorbike bags expose vials to full tropical heat during transit
When ordering in Bali, confirm your supplier uses insulated cold packaging. BioPepTech ships all peptides with cold packs. If a vial arrives warm to the touch, contact us before using it.
See the full Bali storage guide for practical tips specific to the island's climate.
What "Refrigeration" Means in Practice
A standard household refrigerator set to 4°C is appropriate. Check the actual temperature with a refrigerator thermometer — compact fridges and overfull refrigerators often run warmer than their setting suggests.
Do not store peptides:
- In the door (temperature fluctuates with opening)
- Near the freezer compartment (may freeze unexpectedly)
- Next to strong-smelling foods (stoppers can absorb odours through minor permeation)
A small, dedicated section of the main shelf is ideal.
Related Topics
Safety & Regulatory Note
Improperly stored peptides may lose potency or produce unexpected breakdown products. When in doubt, refrigerate. Contact your supplier if you are unsure whether a vial has been temperature-compromised.
References
- 1.Based on manufacturer documentation and published literature on peptide storage and stability.
- 2.Chi EY, et al. (2003). Physical stability of proteins in aqueous solution: Mechanism and driving forces in noncovalent aggregation. Pharmaceutical Research, 20(9), 1325-1336.
- 3.Manning MC, et al. (2010). Stability of protein pharmaceuticals: An update. Pharmaceutical Research, 27(4), 544-575.
